I-Influenza Virus/Influenza B Virus eyomileyo ngokuqandisa
Igama lemveliso
Ikhithi yokuFumana iNucleic Acid ye-HWTS-RT193-eyomileyo ngokuqandisa i-Influenza Virus/Influenza B Virus (i-Fluorescence PCR)
I-Epidemiology
Ngokwee-antigenic umahluko phakathi kwe-NP kunye ne-M genes, iintsholongwane ze-influenza zinokwahlulwa zibe ziintlobo ezine: i-influenza A virus (IFV A), i-influenza B virus (IFV B), i-influenza C virus (IFV C) kunye ne-influenza D virus (IFV D). Kwi-influenza A virus, inee-host ezininzi kunye nee-serotypes ezintsonkothileyo, kwaye inokusasazeka kuzo zonke ii-host ngokusebenzisa i-genetic recombination kunye ne-adaptive mutations. Abantu abanayo i-immunity ehlala ihleli kwi-influenza A virus, ngoko ke abantu bayo yonke iminyaka bahlala besengozini. I-Influenza A virus yeyona pathogens iphambili ebangela ubhubhane lwe-influenza. Kwi-influenza B virus, isasazeka kakhulu kwiindawo ezincinci kwaye okwangoku ayinazo iintlobo ezahlukeneyo. Usulelo lwabantu lubangelwa kakhulu zii-influenza virus ze-B/Yamagata okanye i-B/Victoria lineages. Phakathi kwamatyala e-influenza aqinisekisiweyo ngenyanga kumazwe ali-15 kummandla we-Asia-Pacific, izinga lokufunyaniswa kwe-influenza B virus liqala kwi-0 ukuya kwi-92%. Ngokungafaniyo ne-influenza A virus, amaqela athile abantu, anjengabantwana kunye nabantu abadala, asengozini ye-influenza B virus, enokubangela iingxaki ngokulula, ibeka umthwalo omkhulu kuluntu kune-influenza A virus.
Iiparameters zobugcisa
| Indawo yokugcina izinto | 2-28℃ |
| Beka ubomi kwishelufa | Iinyanga ezili-12 |
| Uhlobo lweSibonelelo | Iswabhu yomphimbo |
| Ct | IFV A，I-IFVB Ct≤35 |
| CV | <5.0% |
| I-LoD | Iikopi ezingama-200/mL |
| Ukuchaneka | Ukudibana kwe-reactivity: Akukho kudibana kwe-reactivity phakathi kwe-kit kunye ne-Bocavirus, i-Rhinovirus, i-Cytomegalovirus, i-Respiratory syncytial virus, i-Parainfluenza virus, i-Epstein-Barr virus, i-herpes simplex virus, i-varicella-zoster virus, i-Mumps virus, i-Enterovirus, i-Measles virus, i-human metapneumovirus, i-Adenovirus, i-human coronaviruses, i-novel coronavirus, i-SARS-CoV, i-MERS-CoV, i-Rotavirus, i-Norovirus, i-Chlamydia pneumoniae, i-Mycoplasma pneumoniae, i-Streptococcus pneumoniae, i-Klebsiella pneumoniae, i-Streptococcus pyogenes, i-Legionella, i-Pneumocystis jirovecii, i-Haemophilus influenzae, i-Bordetella pertussis, i-Staphylococcus aureus, i-Mycobacterium tuberculosis, i-Neisseria gonorrhoeae, i-Candida albicans, i-Candida glabrata, i-Aspergillus fumigatus, i-Cryptococcus neoformans, i-Streptococcus salivarius, i-Moraxella ii-catarrhalis, iLactobacillus, iCorynebacterium kunye ne-human genomic DNA. Uvavanyo lokuphazamisa: I-Mucin (60mg/mL), igazi lomntu (50%), i-Phenylephrine (2 mg/mL), i-Oxymetazoline (2mg/mL), i-Sodium chloride (20mg/mL) ene-5% yesigcini, i-Beclomethasone (20mg/mL), i-Dexamethasone (20mg/mL), i-Flunisolide (20μg/mL), i-Triamcinolone (2mg/mL), i-Budesonide (1mg/mL), i-Mometasone (2mg/mL), i-Fluticasone (2mg/mL), i-Histamine hydrochloride (5 mg/mL), i-Benzocaine (10%), i-Menthol (10%), i-Zanamivir (20mg/mL), i-Peramivir (1mg/mL), i-Mupirocin (20mg/mL), i-Tobramycin (0.6mg/mL), i-Oseltamivir (60ng/mL), i-Ribavirin (10mg/L) zikhethwe ngenxa yokuphazamiseka. uvavanyo, kwaye iziphumo zibonise ukuba izinto eziphazamisayo kumanqanaba angentla azizange ziphazamise iziphumo zovavanyo lwekhithi. |
| Izixhobo Ezisebenzayo | Isebenza kwi-reagent yovavanyo lwe-Type I: Iinkqubo ze-PCR ze-Applied Biosystems 7500 Real-Time, Iinkqubo ze-PCR ze-SLAN-96P zeXesha langempela (iHongshi Medical Technology Co., Ltd.). Isebenza kwi-reagent yovavanyo lwe-Type II: I-EudemonTM AIO800 (HWTS-EQ007) yiJiangsu Macro kunye neMicro-Test Med-Tech Co., Ltd. |
Ukuhamba komsebenzi
I-PCR eqhelekileyo
I-Macro & Micro-Test General DNA/RNA Kit (HWTS-3019) (engasetyenziswa kunye ne-Macro & Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006C, (HWTS-3006B) yiJiangsu Macro & Micro-Test Med-Tech Co., Ltd. ziyacetyiswa xa kutsalwa isampuli kwaye amanyathelo alandelayo kufuneka enziwe ngokuhambelana ne-IFU yeKit.
Umatshini we-AIO800 opheleleyo-kwi-nye
